Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Acumen Pharmaceuticals, Inc. (ABOS) Insider Trading Activity
Healthcare • Biotechnology • 51 employees
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate sabirnetug (ACU193), a recombinant humanized immunoglobulin gamma 2 that completed Phase I clinical trial to target soluble amyloid-beta oligomers. The company has a license agreement with Lonza Sales AG to manufacture and commercialize sabirnetug; and a collaboration and license agreement with Halozyme, Inc. for the development of a subcutaneous formulation of sabirnetug. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Total Value
-$258,984.54
Total Shares
400,934
Average Trade Value
-$14,388.03
Most Active Insider
O Connell Daniel Joseph
Total Activity: $107,975
Largest Single Transaction
$87,873
by O Connell Daniel Joseph on Jan 3, 2025
30-Day Activity
6 Transactions
Volume: 55,436 shares
Value: $91,967
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
CFO Chief Business Officer
Officer
|
Jan 23, 2025 | 28,902 | $49,633 | 231,744 (-12.5%) | Sale | |
|
Chief Medical Officer
Officer
|
Jan 21, 2025 | 3,219 | $5,118 | 170,298 (-1.9%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Jan 21, 2025 | 12,619 | $20,102 | 667,488 (-1.9%) | Sale | |
|
Chief Legal Officer Corp Sec
Officer
|
Jan 21, 2025 | 3,418 | $5,435 | 161,127 (-2.1%) | Sale | |
|
Chief Operating Officer
Officer
|
Jan 21, 2025 | 2,914 | $4,692 | 136,117 (-2.1%) | Sale | |
|
CFO Chief Business Officer
Officer
|
Jan 21, 2025 | 4,364 | $6,986 | 260,646 (-1.7%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Jan 7, 2025 | 225,400 | $0 | 680,107 (+33.1%) | Grant | |
|
Chief Legal Officer Corp Sec
Officer
|
Jan 6, 2025 | 66,800 | $0 | 164,545 (+40.6%) | Grant | |
|
Chief Regulatory Officer
Officer
|
Jan 6, 2025 | 8,800 | $0 | 8,800 (+100.0%) | Grant | |
|
President and Cdo
Officer
|
Jan 6, 2025 | 62,600 | $0 | 62,600 (+100.0%) | Grant | |
|
CFO Chief Business Officer
Officer
|
Jan 6, 2025 | 66,800 | $0 | 265,010 (+25.2%) | Grant | |
|
Chief Operating Officer
Officer
|
Jan 6, 2025 | 49,800 | $0 | 139,031 (+35.8%) | Grant | |
|
Chief Medical Officer
Officer
|
Jan 6, 2025 | 66,800 | $0 | 173,517 (+38.5%) | Grant | |
|
Chief Legal Officer Corp Sec
Officer
|
Jan 3, 2025 | 11,122 | $20,506 | 97,745 (-11.4%) | Sale | |
|
Chief Medical Officer
Officer
|
Jan 3, 2025 | 10,859 | $20,047 | 106,717 (-10.2%) | Sale | |
|
CFO Chief Business Officer
Officer
|
Jan 3, 2025 | 13,235 | $24,367 | 198,210 (-6.7%) | Sale | |
|
Chief Executive Officer
Director, Officer
|
Jan 3, 2025 | 47,778 | $87,873 | 454,707 (-10.5%) | Sale | |
|
Chief Operating Officer
Officer
|
Jan 3, 2025 | 7,636 | $14,225 | 89,231 (-8.6%) | Sale |